Article

Quiz: Which RA drug has the least negative impact on bone mineral density?

Author(s):

Ingrid Torjesen

Patients with rheumatoid arthritis are at increased risk for osteoporosis. This heightened risk of osteoporosis can be due to a combination of factors: inactivity due to the pain and loss of joint function associated with the disease, a direct the rheumatoid arthritis disease process, and their treatment for rheumatoid arthritis. In this quiz, test your knowledge on the risk of osteoporosis in rheumatoid arthritis and how it should be treated.

Which of the following factors do not increase the risk of osteoporosis in patients with rheumatoid arthritis?

a) Female sex

b) Post-menopause

c) Low BMI

d) Elderly

e) Lack of vitamin D

f) Smoking

g) Drinking alcohol

h) Anemia


Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Related Content
People With Fibromyalgia May Have Impaired Mitochondrial Function
January 23rd 2025

People With Fibromyalgia May Have Impaired Mitochondrial Function

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Sizheng Steven Zhao, MBChB, PhD, Clinical Lecturer at the Centre for Musculoskeletal Research, University of Manchester, United Kingdom
January 21st 2025

JAKi Treatment for Psoriatic Arthritis Not Associated With Increased CVD, VTE, Cancer Risk

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Cluster Headache Often Comorbid with Fibromyalgia, Migraine
January 18th 2025

Cluster Headache Often Comorbid with Fibromyalgia, Migraine

Chelsie Derman
Research Confirms Cold Therapy Benefits During Gout Flares
January 17th 2025

Research Confirms Cold Therapy Benefits During Gout Flares

Victoria Johnson
© 2025 MJH Life Sciences

All rights reserved.